Tranexamic Acid in Oncology

Abstract

Get full access to this article

View all access options for this article.

References

Ben-Bassat

Douer

Ramot

. Tranexamic acid in acute myeloid leukemia: possible reduction of platelet transfusions. Eur J Haematol 1990; 45: 86–9.

Fricke

Alling

Kimball

Griffith

Klein

. Lack of efficacy of tranexamic acid in thrombocytopenic bleeding. Transfusion 1991; 31: 345–8.

Package insert. Cyklokapron (tranexamic acid). Stockholm: KabiVitrum AB, 1987.

Sindet-Pedersen

Stenbjerg

. Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J Oral Maxillofacial Surg 1986; 33: 703–7.

Gardner

Helmer

. Aminocaproic acid — use in control of hemorrhage in patients with amegakaryocytic thrombocytopenia. JAMA 1980; 243: 35–7.

Okamoto

Sato

Takada

Okamoo

. An active stereoisomer (trans form) of AMCHA and its antifibrinolytic (antiplasminic) action in vitro and in vivo. Keio J Med 1964; 13: 177–85.

Pogliani

Salvatore

Masera

Corneo

. Antifibrinolytic therapy in acute promyelocytic leukemia. Acta Haematol 1989; 81: 58–9.

Avvisati

Ten Cate

Buller

Mandelli

. Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. Lancet 1989; 2: 122–4.

Sugawara

Okuda

Yamaguchi

Endo

Yoshinaga

. Successful treatment with tranexamic acid for severe bleeding in acute promyelocytic leukemia (letter). Acta Haematol 1992; 87: 109.

10.

De Boer

Koolen

MGJ

Roos

Ten Cate

. Tranexamic acid treatment of hemothorax in two patients with malignant mesothelioma. Chest 1991; 100: 847–8.

11.

Cyklokapron. Drug topics red book. Montvale, NJ: Medical Economics, 1995: 194.